Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil.

Source:http://linkedlifedata.com/resource/pubmed/id/17113215

Download in:

View as

General Info

PMID
17113215